Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by LimmaTech Biologics AG

LimmaTech Awarded FDA Fast Track Designation for Vaccine Candidate Against Staphylococcus aureus
From LimmaTech Biologics AG
Via Business Wire
LimmaTech Appoints Staph Leavenworth Bakali as Chairman of the Board
From LimmaTech Biologics AG
Via Business Wire
LimmaTech Biologics Raises $37 Million Series A to Advance Its Pipeline of Vaccines Against Multidrug-Resistant Bacterial Infections
From LimmaTech Biologics AG
Via Business Wire
LimmaTech Enters Exclusive License and Collaboration Agreement with Griffith University to Expand its Vaccine Technology Platform
From LimmaTech Biologics AG
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.